With production stalling and oil prices dropping, operators could focus on recovery rates and inventory, analysts say ...
1. During the "14th Five-Year Plan" period, Ethylene Glycol (MEG) underwent a series of developments: capacity expansion, output growth, profit compression, phased declines in operating rates, reduced ...
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback